🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and effectiveness of CA...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-09-01
Trial ID
NCT04406610
Treatments Being Tested
The aim of this clinical trial is to assess the feasibility, safety and eff...
Status
Not Yet Recruiting
Location
Shenzhen Geno-Immune Medical Institute
Start Date
2027-07-01
Trial ID
NCT04433221
Treatments Being Tested
In this study, there are two treatment groups called Cohort 1 and Cohort 2....
Status
Recruiting
Location
Texas Children's Hospital
Start Date
2020-02-03
Trial ID
NCT04099797
Treatments Being Tested
Patients with refractory and/or recurrent neuroblastoma have poor prognosis...
Status
Completed
Location
Zhujiang Hospital of Southern Medical University
Start Date
2016-01-01
Trial ID
NCT02765243
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of CA...
Status
Withdrawn
Location
Central laboratory in Fuda cancer hospital
Start Date
2015-10-15
Trial ID
NCT03252171
Treatments Being Tested
This single-arm, multicenter clinical study will treat the patient who have...
Status
Unknown
Location
Nanjing Children's Hospital
Start Date
2016-09
Trial ID
NCT02919046
Treatments Being Tested
The purpose of this study is to assess the feasibility, safety and efficacy...
Status
Not Yet Recruiting
Location
Shenzhen Geno-Immune Medical Institute
Start Date
2027-06-30
Trial ID
NCT06739226
Treatments Being Tested
Background GD2 is a well-characterized tumor antigen in neuroblastoma, whi...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2014-02-28
Trial ID
NCT02107963
Treatments Being Tested
Subjects that have relapsed or refractory neuroblastoma are invited to take...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
Start Date
2013-08
Trial ID
NCT01822652
Treatments Being Tested
The purpose of this study is to test the safety and efficacy of iC9-GD2-CAR...
Status
Recruiting
Location
Ospedale Pediatrico Bambino Gesù
Start Date
2023-11-09
Trial ID
NCT05298995
Treatments Being Tested